Drugs / N0783
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07318350 | Oct 2026 → Mar 2028 expected | — | Eurofarma Laboratorios S.A. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N0783 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07318350 ↗ |
| Route | Inhaled | “administered via inhalation” NCT07318350 ↗ |